Benzinga's Top Downgrades - Evoke Pharma (NASDAQ:EVOK)

Stifel Nicolaus downgraded Hyatt Hotels Corporation H from Buy to Hold. Hyatt shares rose 0.02 percent to $51.27 in pre-market trading.
Analysts at PiperJaffray downgraded Guess?, Inc. GES from Neutral to Underweight. Guess? shares fell 4.75 percent to $14.65 in pre-market trading.
Societe Generale downgraded Halliburton Company HAL from Buy to Hold. Halliburton shares slipped 0.33 percent to $45.46 in pre-market trading.
Raymond James downgraded ARM Holdings plc (ADR) ARMH from Outperform to Market Perform. ARM Holdings shares fell 0.86 percent to $65.60 in pre-market trading.
Noble Financial downgraded Evoke Pharma Inc EVOK from Buy to Hold. Evoke Pharma shares declined 0.69 percent to $2.87 in pre-market trading.
Analysts at Atlantic Equities downgraded Oracle Corporation ORCL from Overweight to Neutral. Oracle shares dropped 0.50 percent to $41.43 in pre-market trading.
Analysts at Longbow Research downgraded PACCAR Inc PCAR from Neutral to Underperform. PACCAR shares declined 1.91 percent to $53.50 in pre-market trading.
Analysts at DA Davidson downgraded Super Micro Computer, Inc. SMCI from Buy to Neutral. Super Micro Computer shares fell 25.97 percent to $19.50 in pre-market trading.
BMO Capital downgraded Maxim Integrated Products Inc. MXIM from Outperform to Market Perform. Maxim Integrated Products shares declined 1.23 percent to $37.65 in pre-market trading.
JP Morgan downgraded Michaels Companies Inc MIK from Overweight to Neutral. Michaels Companies shares rose 2.80 percent to close at $27.56 on Monday.

Market News and Data brought to you by Benzinga APIs